Biotech Pulse vs e

The biotech catalyst tracker for serious investors. Real-time FDA approvals, PDUFA dates, EMA and CHMP committee opinions, SEC filings, clinical trial readouts, and primary-source company news — pushed the moment they hit the regulatory record. WHO IT'S FOR Biotech investors, pharma analysts, healthcare hedge funds, and retail traders who need to see what just happened on a name BEFORE the wire-service summary hits Twitter. FREE FEATURES (no account, no signup) • Real-time FDA approval, PDUFA, CRL, and Warning Letter alerts • EU EMA marketing authorisation feed (UK + EEA centralised approvals) • SEC 8-K filings, press releases, and clinical trial updates • Forward catalyst calendar with PDUFA, AdCom, and CHMP dates • Push notifications when a watchlisted ticker has an event • Watchlist + per-ticker News, Pipeline, Drugs, Intelligence tabs • Indication / drug-class search ("multiple sclerosis", "GLP-1", "CAR-T") • Drug detail with FAERS adverse-event severity and primary-source link to Drugs@FDA • Watchlist Compare view — side-by-side pipeline depth + next catalyst BIOTECH PULSE PRO ($9.99/mo or $79.99/yr, with 7-day free trial) Twelve institutional-grade Pro features, every one sourced from a primary regulatory or scientific feed: • Insider buys — SEC Form 4 executive open-market purchases, 10b5-1 plans filtered out • 13F institutional holdings — quarterly changes, biotech-whale callouts (Baker Bros, BVF, RA Capital, Perceptive) • 8-K dilution radar — automatic offering / shelf / ATM classification • 8-K Item 8.01 content classifier — CRL, PDUFA, AdCom, trial readout, partnership, regulatory filing categories • Material agreements — 8-K Item 1.01 partnership / licensing / supply detection • AdCom calendar — Federal Register FDA Advisory Committee meetings + briefing-doc URLs • Orange Book + USPTO patent timelines — every unexpired patent with USPTO Patent Term Adjustment chips (PTA extends patent expiry past the Orange Book listing — the most under-priced biotech signal), Re-exam warning flags, family-size hints, and one-tap to the patent document on Google Patents • FDA Warning Letter history • FDA device clearances — 510(k) and PMA by manufacturer • DailyMed label history — every SPL version bump (indication, black-box, REMS) • CMS Open Payments — KOL payment network per sponsor • CMS Part D utilization — 5 years of Medicare prescription volume • Drug shortages — FDA-tracked active shortages with push alerts on status changes • Conference abstracts — ASH, ASCO, AHA, AAN, DDW • Custom alert rules — unlimited, all 4 trigger types including 8-K Item filtering 100% PRIMARY-SOURCE DATA SEC EDGAR. openFDA. EMA. CHMP. Health Canada. CMS. NIH. Federal Register. ClinicalTrials.gov. DailyMed. USPTO. ash.confex.com. No Bloomberg, no Refinitiv, no FactSet, no paid data vendors. No AI hallucinations. No analyst recommendations. Just the data. NO TRACKING No analytics SDK. No advertising SDK. No cross-app tracking. No account required. External article links open in Safari's isolated process. We don't know who you are. Pro auto-renews unless cancelled at least 24 hours before the end of the current period. Cancel anytime in iOS Settings → Apple ID → Subscriptions. Terms of Use: https://bioturd.com/terms Privacy Policy: https://bioturd.com/privacy

e-MyStocks is an earnings tracker built for retail traders who want more signal than a calendar. — WHAT YOU GET — • Earnings calendar across thousands of US stocks (NYSE + NASDAQ + AMEX), sorted by days until report, with BMO / AMC timing. • Multi-quarter growth trends. Revenue and EPS year-over-year for the last 4 quarters, with acceleration/deceleration arrows that tell you at a glance whether the business is speeding up or slowing down. • Consensus & beat rates. Analyst consensus vs. historical actuals. See a company's beat streak and estimate-revision direction before the report lands. • Live momentum signal. BUY / SELL / HOLD tags for S&P 500 names, refreshed every 15 minutes during US market hours. Includes a "will flip on next bar" indicator so you can see setups about to trigger. • Post-earnings drift matrix. What actually happened to a stock 1, 3, 5, and 20 days after past reports — so you can see whether the market tends to fade or extend a beat. • Options implied move. The straddle-implied 1-day move priced in before each report, side-by-side with the actual historical reaction. • Playbook cards. For candidate stocks, a short plain-English breakdown of the setup: why the signal fired, where the risk is, what would invalidate it. • Insights hub. Market Movers, PEAD Drift Matrix, Earnings Duel head-to-head, Analyst Upside leaderboard, Earnings Scoreboard, Tonight's Hot List, 52-Week Range Position, Smart Screens, and Implied vs Realized Move — all in one place. • Personal watchlist with local earnings reminders, always-on daily change pill (live during market hours, "Fri close" qualifier outside of them), sector heatmap, and full analyst outlook on every detail page. — HOW IT WORKS — Fundamentals come from SEC EDGAR filings and Yahoo Finance. Prices, analyst ratings, and price targets come from Financial Modeling Prep. Everything is refreshed before market open, topped up every 15 minutes during hours, and republished 90 minutes after close so the day's actual closing prices land on your watchlist. — WHAT THIS IS NOT — e-MyStocks is an informational and educational tool. It is not investment advice, a brokerage, or a recommendation service. All decisions are yours. — PRIVACY — Watchlist and preferences live on your device — we never upload them. Sign-in (optional) only enables the live momentum signal stream. You can delete your account at any time from the profile menu. Full privacy policy: https://e-mystocks.web.app/privacy